SCHEMBL7223095

SCHEMBL7223095

Nc1ccc2c(c1)C(=O)[N]C2=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 5/20 0.50
ALDH1A1 P00352 4/20 0.50
RAB9A P51151 4/20 0.50
TSHR P16473 4/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
MAPK1 P28482 2/20 0.50
TP53 P04637 1/20 0.50
CYP3A4 P08684 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
MEN1 O00255 3/20 0.48
KMT2A Q03164 3/20 0.48
PTPRC P08575 2/20 0.48
LMNA P02545 2/20 0.48
NPSR1 Q6W5P4 2/20 0.48
POLB P06746 2/20 0.48
APAF1 O14727 1/20 0.48
TDP2 O95551 1/20 0.48
NSD2 O96028 1/20 0.48
PLA2G1B P04054 1/20 0.48
CTSL P07711 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2970333 0.86 NPC1 (0.50) NPC1ALDH1A1RAB9ATSHRSMN1; SMN2
SCHEMBL864582 0.72 NPC1 (0.77) NPC1ALDH1A1RAB9ATSHRSMN1; SMN2
SCHEMBL5551699 0.72 S100A4 (0.82) NPC1ALDH1A1RAB9ATSHRSMN1; SMN2
SCHEMBL3135129 0.72 NPC1 (0.86) NPC1ALDH1A1RAB9ATSHRSMN1; SMN2
SCHEMBL516210 0.72 NPC1 (0.86) NPC1ALDH1A1RAB9ATSHRSMN1; SMN2
SCHEMBL30350052 0.72 NPC1 (0.77) NPC1ALDH1A1RAB9ATSHRSMN1; SMN2
SCHEMBL7915048 0.72 PTPRC (0.82) NPC1ALDH1A1RAB9ATSHRSMN1; SMN2
SCHEMBL9019051 0.72 NPC1 (0.77) NPC1ALDH1A1RAB9ATSHRSMN1; SMN2
SCHEMBL5510043 0.71 MAOB (0.52) GAAMAPTCA9CDK5
SCHEMBL3418531 0.71 CASP3 (0.42) TDP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6605604-B1 Tumour necrosis factor alpha release inhibitors; efficiency treatment of cancers, rheumatic diseases, arthritis, ulcers, atherosclerosis, asthma LES LABORATOIRES SERVIER (FR) 2003-08-12 US disclosed